Skip to main content
SpringerLink
Log in

GNAQ and GNA11 mutations in melanocytomas of the central nervous system

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Adameyko I, Lallemend F, Aquino JB et al (2009) Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell 139:366–379

    Article  PubMed  CAS  Google Scholar 

  2. Brat DJ, Perry A (2007) Melanocytic lesions. In: Louis DN, Ohgaki H, Wiestler OD et al (eds) WHO classification of tumours of the nervous system, IARC Press, Lyon, pp 181–183

  3. Kusters-Vandevelde HV, Klaasen A, Kusters B et al (2010) Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system. Acta Neuropathol 119:317–323

    Article  PubMed  Google Scholar 

  4. McLean IW, Foster WD, Zimmerman LE (1982) Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol 13:123–132

    Article  PubMed  CAS  Google Scholar 

  5. Van Raamsdonk CD, Barsh GS, Wakamatsu K et al (2009) Independent regulation of hair and skin color by two G protein-coupled pathways. Pigment Cell Melanoma Res 22:819–826

    Article  PubMed  Google Scholar 

  6. Van Raamsdonk CD, Bezrookove V, Green G et al (2009) Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457:599–602

    Article  PubMed  Google Scholar 

  7. Van Raamsdonk CD, Griewank KG, Crosby MB et al (2010) Mutations in GNA11 in uveal melanoma. N Engl J Med 363:2191–2199

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Harry J. Lloyd Translational Research Award and Lucille Castori Fellowship [R.M.]; Max-Kade Fellowship andJubilaeumsfonds of the Oesterreichische Nationalbank (13837) [T.W.]; US National Institutes of Health (R01 CA131524 and CA142873) and a Melanoma Research Alliance Team Science Award [B.C.B.].

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Pathology, and Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA

    Rajmohan Murali

  2. Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, USA

    Thomas Wiesner

  3. Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, USA

    Marc K. Rosenblum

  4. Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA

    Boris C. Bastian

Authors
  1. Rajmohan Murali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Wiesner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marc K. Rosenblum
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Boris C. Bastian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rajmohan Murali.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murali, R., Wiesner, T., Rosenblum, M.K. et al. GNAQ and GNA11 mutations in melanocytomas of the central nervous system. Acta Neuropathol 123, 457–459 (2012). https://doi.org/10.1007/s00401-012-0948-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-012-0948-x

Keywords

Search

Navigation